Zhao Y, Ma Y, Fan Y, Zhou J, et al. A multicenter, open-label phase Ib/II study of cadonilimab (anti PD-1 and CTLA-4
bispecific antibody) monotherapy in previously treated advanced non-small-cell
lung cancer (AK104-202 study). Lung Cancer 2023;184:107355.
PMID: 37677918